Cape Investment Advisory’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17K Buy
+313
New +$15.2K ﹤0.01% 732
2026
Q1
– Sell
-315
Closed -$13.8K – 514
2025
Q4
$13.8K Buy
+315
New +$13K ﹤0.01% 686
2025
Q3
– Sell
-65
Closed -$2.87K – 952
2025
Q2
$2.87K Hold
65
– – ﹤0.01% 876
2025
Q1
$2.4K Sell
65
-35
-35% -$1.25K ﹤0.01% 867
2024
Q4
$3.33K Hold
100
– – ﹤0.01% 816
2024
Q3
$2.6K Hold
100
– – ﹤0.01% 794
2024
Q2
$2.25K Hold
100
– – ﹤0.01% 774
2024
Q1
$2.37K Buy
+100
New +$2.22K ﹤0.01% 748

Other funds holding EXEL

Cape Investment Advisory's EXEL Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Exelixis (EXEL) in Q2 2026: 313 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #732 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in EXEL as recently as Q4 2025.

Cape Investment Advisory first reported a position in EXEL in Q1 2024 and has held it in 8 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Cape Investment Advisory held 313 shares of Exelixis worth $17K as of Q2 2026.
  • Exelixis was a new Cape Investment Advisory position in Q2 2026.
  • Exelixis made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #732 holding.
  • Cape Investment Advisory first reported a position in Exelixis in Q1 2024 and has held it in 8 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.